TY  - BOOK
AU  - Polak, Dame Julia
AU  - Prescott, C. D
AU  - Polak, Julia M
TI  - The delivery of regenerative medicines and their impact on healthcare
SN  - 9781439836064 
U1  - 610.28 PRE 
PY  - 2011///
CY  - Boca Raton, London, New York
PB  - CRC Press/Taylor & Francis
KW  - Health Care Sector
KW  - Regenerative Medicine
KW  - Tissue engineering - Economic aspects
KW  - Regenerative medicine - Economic aspects
KW  - Medical care - Economic aspects
N1  - <p>Includes bibliographical references and index.</p>; (Publisher-supplied data) WHAT IS REGENERATIVE MEDICINE / Julia Polak -- A NEW POLITICAL-FINANCIAL PARADIGM FOR MEDICAL RESEARCH: THE CALIFORNIA USA   MODEL / Robert Klein/Alan Trounson -- INVESTMENT MODELS 4. PUBLIC FUNDING IN AUSTRALIA / Graham Macdonald -- CANADA: CAPITALISING ON A 50-YEAR LEGACY / Andrew Lyall -- INVESTING IN REGENERATIVE MEDICINE: WHAT DRIVES THE PRIVATE INVESTOR? / Cathy Prescott -- PUBLIC INVESTMENT MODELS: COMING OUT OF THE CLOSET AND GOING PUBLIC! / Reni Benjamin -- CELL-BASED PRODUCTS: ALLOGENIC / Paul Kemp -- AUTOLOGOUS CELL BASED PRODUCTS: FULFILLING THE PROMISE OF CELL THERAPY / Eduardo Bravo, Magdalena Blanco-Molina -- BUSINESS MODELS FOR CORD BLOOD / Suzanne Watt -- CHANGING THE GAME OF DRUG DISCOVERY / John Walker -- DISCOVERY OF SMALL MOLECULE REGENERATIVE DRUGS / Yen Choo -- THE ADOPTION OF THERAPEUTIC STEM CELL TECHNOLOGIES BY LARGE PHARMACEUTICAL COMPANIES / Alain Vertes -- ROLE OF TOOLS AND TECHNOLOGIES COMPANIES IN THE SUCCESSFUL COMMERCIALIZATION OF REGENERATIVE MEDICINE / Joydeep Goswami --  KEY CONSIDERATIONS IN MANUFACTURING OF CELLULAR THERAPIES / Robert Preti --   STATE OF THE GLOBAL REGENERATIVE MEDICINE INDUSTRY /  Lee Buckler, R. Margolin, S. Haecker -- REGENERATING IP: EUROPE AFTER WARF Julian Hitchcock and Devanand Crease -- PROTECTING REGENERATIVE MEDICINE INTELLECTUAL PROPERTY IN THE USE:  PROBLEMS AND STRATEGIES / David Resnick, Ronald Eisenstein, Joseph McWilliams -- IMPACT OF INDIAN POLICIES AND LAWS ON REGENERATIVE MEDICINE PATENT   APPLICATIONS / Prabuddha Ganguli  -- A CATalyst FOR CHANGE: REGULATING REGENERATIVE MEDICINES IN EUROPE / Christopher Bravery -- THE US REGULATORY REIMBURSEMENT POLITICAL ENVIRONMENT AND STRATEGIES FOR REFORM / Michael Werner
N2  - "Based on input from an international panel of experts, this book provides first-hand experience of the challenges and opportunities facing the delivery of regenerative medicines to patients. It highlights key issues beyond science and clinical translation, such as finance and business models, intellectual property and regulatory landscapes as well as questions of how regenerative medicines will be evaluated for reimbursement. This book will become a pivotal reference to anyone within the healthcare sector interested in understanding and investing in the delivery of regenerative medicines to the benefit of patients"--Provided by publisher
ER  -